Abstract:IntroductionPreformulation development studies for biologics are typically focused on evaluating the impact of various formulation components (pH, buffer, excipients, etc.) on the physical and chemical stability profiles of the active molecule. During the early development stages, the sample availability and information regarding the degradation profile of the protein can be limited. This necessitates the development of a high throughput screening method that requires small sample quantity and enables evaluation of wide experimental design space without required significant resource, material, or time.Methods and ResultsThis manuscript summarizes a fluorescence-based screening method that was evaluated and developed to rank order formulations based on relative physical stability profile (i.e., extent of aggregation). The development studies were conducted using three model protein systems with different molecular weight, isoelectric point, and protein type (.e.g., monoclonal antibody and fusion proteins). This method primarily relies on the detection of an increase in fluorescence intensity (FI) of an external dye when bound to exposed hydrophobic surfaces on protein aggregates. The method was successfully developed in a 96-well plate format and incorporated into an automation platform. The relative stability profiles were determined using the fluorescence-based screening. Method performance was evaluated with respect to repeatability, reproducibility, and linearity (for both protein and dye concentration). In addition, this method was also applied in order to accurately determine low concentrations of surfactants. Based on the study outcomes, recommendations to be considered while incorporation of high throughput screening fluorescence method into the preformulation development workflow are provided.ConclusionThe fluorescence method described herein can be implemented as an orthogonal tool to evaluate relative physical stability profile, with significantly higher throughput than other methods such as SEC-HPLC, gel electrophoresis, and analytical ultracentrifugation.

A Fluorescence-Detection Size-Exclusion Chromatography-Based Thermostability Assay for Membrane Protein Precrystallization Screening

Fluorescence-Detection Size-Exclusion Chromatography-Based Thermostability Assay for Membrane Proteins.

General qPCR and Plate Reader Methods for Rapid Optimization of Membrane Protein Purification and Crystallization Using Thermostability Assays

An efficient screening method for purifying and crystallizing membrane proteins using modified clear-native PAGE

Lcp-T-M: an Assay to Measure and Understand Stability of Membrane Proteins in A Membrane Environment

Recent Advances in Expression Screening and Sample Evaluation for Structural Studies of Membrane Proteins

Analysis of Protein Stability and Ligand Interactions by Thermal Shift Assay

Automated High-Throughput Nanoliter-Scale Protein Crystallization Screening.

Investigation of F508del CFTR unfolding and a search for stabilizing small molecules

Fluorescence-detection size-exclusion chromatography utilizing nanobody technology for expression screening of membrane proteins

The GFP thermal shift assay for screening ligand and lipid interactions to solute carrier transporters

Quantification of free cysteines in membrane and soluble proteins using a fluorescent dye and thermal unfolding

Fluorescence Thermal Shift Assay based High Through-put Screening in Small Molecule Drug Discovery: A Brief Overview

Screening of Buffers and Additives for Protein Stabilization by Thermal Shift Assay: A Practical Approach

A Novel Cryo-Electron Microscopy Support Film Based on 2D Crystal of HFBI Protein

Fluorescence-Based Protein Stability Monitoring—A Review

High-Fidelity Assay Based on Turn-Off Fluorescence to Detect the Perturbations of Cellular Proteostasis

An Improved Fluorescent Tag and Its Nanobodies for Membrane Protein Expression, Stability Assay, and Purification

Feedback-System-Control Integrated Microfluidic System for Fast Screening of Protein Crystallization Conditions

High Throughput Fluorescence Assay to Detect Aggregation During Biologics Formulation Development

Accessibility to internal cavities and ligand binding sites monitored by protein crystallographic thermal factors